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ABSTRACT
The human immunodeficiency virus (HIV) Vif protein
blocks incorporation of two host cell cytidine
deaminases, APOBEC3F and 3G, into the budding
virion. Not surprisingly, on a vif background
nascent minus strand DNA can be extensively
edited leaving multiple uracil residues. Editing
occurs preferentially in the context of TC (GA on
the plus strand) and CC (GG) depending on the
enzyme. To explore the distribution of APOBEC3F
and –3G editing across the genome, a product/
substrate ratio (AA 1 AG)/(GA 1 GG) was computed
for a series of 30 edited genomes present in the data
bases. Two highly polarized gradients were noted
each with maxima just 50 to the central polypurine
tract (cPPT) and LTR proximal polypurine tract
(30PPT). The gradients are in remarkable agreement
with the time the minus strand DNA remains single
stranded. In vitro analyses of APOBEC3G deamina-
tion of nascent cDNA spanning the two PPTs
showed no pronounced dependence on the PPT
RNA:DNA heteroduplex ruling out the competing
hypothesis of a PPT orientation effect. The degree of
hypermutation varied smoothly among genomes
indicating that the number of APOBEC3 molecules
packaged varied considerably.
INTRODUCTION
Cytidine deaminases of the human APOBEC3 family, particu-
larly APOBEC3B, 3C, 3F and 3G, edit cytidine residues only
in the context of single-stranded DNA (1–12). The genes are
relatively well expressed in lymphocytes and some may be
induced by interferon-a and -g in vitro and in vivo (13–15).
As such these enzymes represent a potential barrier to the
replication of retroviruses that replicate via a single-stranded
minus strand DNA intermediate. To counter restriction
by APOBEC3F and 3G human immunodeﬁciency virus-1
(HIV-1) encodes a vif gene whose product, the Vif protein,
is capable of excluding them from budding virions (3–7,
9,11,16). As all but one of the other lentiviruses encode a vif
gene it is presumed that they too are susceptible to genetic
editing by APOBEC3 orthologs (17–21). On the background
of a lesion in the HIV-1 vif gene, either APOBEC3F or 3G
is incorporated into the budding virion (2–7,9,11,12,16). Fol-
lowing infection of a target cell, cDNA synthesis ensues.
However, C residues in the nascent single DNA strand can
now be edited to U resulting in the collapse of viral informa-
tion. Monotonous substitution of C for U on the minus strand
shows up as numerous G!A transitions on the reference
viral (+) strand, hence their name, G!A hypermutants
(2–7,9,11,12,16). The ﬁne substrate speciﬁcities of human
APOBEC3F and 3G are subtly different, the former preferring
the TC dinucleotide (GA on the plus strand) to CC (GG) where
the edited base is underlined. APOBEC3G shows an inverse
preference, i.e. CC (GG) > TC (GA) (1–3,5,8,9,12,22).
HIV minus strand DNA synthesis is primed by tRNAlys3
bound to the primer binding site (PBS) and does not differ
qualitatively to that of other retroviruses. However, plus
strand DNA synthesis is initiated at two RNA polypurine
tracts (PPT) that remain associated with the minus strand
cDNA. The ﬁrst of these RNA primers is located within the
integrase gene while the second maps immediately upstream
of the 30-LTR, the two being referred to as cPPT and 30PPT,
respectively. Dual initiation sites of plus strand DNA is a
particular trait of the lentiviruses and spumaviruses (23,24).
Given the priming of DNA synthesis at ﬁxed sites on the
genome and a ﬁnite velocity of DNA synthesis, it follows
that not all cytidine residues will remain single stranded for
the same period of time. Accordingly, the extent of editing
should be dependent on the lifetime a C residue remains sin-
gle stranded, assuming no product inhibition, which in turn
suggests that the distribution of edited sites across the gen-
ome may well be non-random. Ideally such a hypothesis
could be best addressed by comparisons of full-length HIV
hypermutated genomes along with a normal sequence from
the same sample.
A collection of 30 nearly full-length hypermutated
sequences was recovered from the HIV databases and the
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lyzed. Although nearly half were lightly edited and hence
relatively uninformative, two relatively smooth gradients
of APOBEC3 editing of HIV-1 minus strand DNA were
apparent culminating in maxima just 50 to the two PPTs.
In vitro editing experiments show that there is no orientation
effect of the PPT RNA:DNA heteroduplex on editing. The
twin gradients are consistent with the replication dynamics
of HIV-1.
MATERIALS AND METHODS
Hypermutated HIV-1 sequences were identiﬁed by screening
the databases with a variety of key words such as ‘HIV,
hypermutation’ and ‘HIV, hypermutated’. A total of 29
nearly full-length and 1 complete genome were identiﬁed.
As the 50 and 30 ends of the sequences differed somewhat—
reﬂecting the use of different ampliﬁcation primers—they
were trimmed so as to generate two groups of sequences
encompassing  95% (n ¼ 22) and  92% (n ¼ 7) of unique
sequence HIV-1. All have a common 50 extremity mapping to
the beginning of the gag coding region while the 30 extre-
mities mapped to the U3 region of the distal LTR. The exten-
sively G!A hypermutated and reference sequences derived
from the HIV-1 group O strain Vau have been published
previously (25). A total of 20 sequences were used as non-
hypermutated controls. They were selected from the Los
Alamos HIV database and spanned all HIV-1 clades. The
non-hypermutated HIV-1 O sequence Vau was also analyzed.
The accession numbers of all sequences are given in Table 1.
For the calculation of the ‘product substrate ratio’ (PS ratio)
across the genome, a simple program was written in Java,
a copy of which can be found at http://www.pasteur.fr/
recherche/unites/gmp/sitegmp/APOBEC3-PSratio.html. It cal-
culates the number of AG, AA, GG, GA dinucleotides and the
AG + AA/GG + GA ratio within a sliding window of variable
length and interval. We found a window of 600 bp displaced at
50 bp intervals to be visually clear.
In vitro deamination of PPT loci
Two loci spanning the central and 30PPTs were analyzed
in vitro for APOBEC3G deamination of nascent minus strand
cDNA. DNA spanning the cPPT and 30PPT were ampliﬁed
from the LAI molecular clone using primers pairs T7/
cPPT+30/cPPT and T7/30PPT+30/30PPT, respectively. T7/
cPPT, GCGAATTTAATACGACTCACTATAGGGAGCA-
GCAATTTCACCAGTACTACGGTT; 30/cPPT, CCTTCA-
CCTTTCCAGAGGAGCTTT; 50/cPPT, GCAGCAATTTCA-
CCAGTACTACRGTT; T7/30PPT, GCGAATTTAATACG-
ACTCACTATAGGGACTTGGAAAGGATTTTGCTATAA;
30/30PPT, ACAAGCTGGTGTTCTCTCCTTTA; 50/30PPT,
GCGCTTRRAAARRATTTTGCTATAA, where R ¼ Go rA .
The T7 RNA polymerase promoter is underlined. RNA was
made from uncloned PCR products while cDNA synthesis,
as well as the deamination assay, were performed as des-
cribed previously (8,26). Reaction volumes, times and tem-
peratures were 50 ml, 3 h and 37 C, respectively. Sufﬁcient
material for subsequent cloning was recovered from the
cDNA reactions by PCR in 12 cycles using the primer pairs
50/cPPT + 30/cPPT and 50/30PPT + 30/30PPT, respectively.
PCR products were cloned into the TOPO TA cloning vector
and DNA sequenced using Big Dye terminators. HIV-1 RT
was purchased from Amersham. Human APOBEC3G was
expressed as a GST fusion protein using a recombinant
Baculovirus and puriﬁed as described previously (8).
RESULTS AND DISCUSSION
Twin gradients for APOBEC3 editing
To date the only full-length G!A hypermutated HIV-1
sequence was fortunately accompanied by an unedited refer-
ence sequence from the same DNA sample (25). Comparison
of the number of edited residues within a non-overlapping
sliding window of 200 bp across the genome shows a dis-
tinctly non-random distribution (Figure 1). At a macroscopic
level there were two minima 30 to the PBS and cPPT and two
maxima both 50 to the cPPT and 30PPT (black line). The sig-
nal was strongest in the context of CC and TC dinucleotides
(blue) to the detriment of GC and AC (red), which is in
keeping with the preference of APOBEC3F and 3G for
these targets (1–3,5,8,9,12,22).
To see if this was a general ﬁnding a total of 29 nearly full-
length G!A hypermutated sequences (92–95%) were recov-
ered from GenBank. Unfortunately none was accompanied
Table 1. Collection of hypermutated genomes and selected reference
sequences
Hypermutated sequences Reference sequences
Code Accession
number
Clade* Code Accession
number
Clade*
H1 AY037273 B/F R1 AF004885 A
H2 AF362994 CRF01_AE/B R2 AF005496 H
H3 AF442566 A/D R3 AF061641 G
H4 AF442568 A/D R4 AF067155 C
H5 AF442570 A/D R5 AF077336 F1
H6 AF457057 A R6 AF082394 J
H7 AF457060 A2/D R7 AF286224 C
H8 AF457071 A R8 AF286237 A2
H9 AF457074 A/D R9 AF361872 A
H10 AF457076 A R10 AF361874 C
H11 AF457091 A R11 AF377956 F2
H12 AF484484 A R12 K02013 B
H13 AY037274 B R13 K03454 D
H14 AY037276 B/F R14 M26727 B
H15 AY237165 A/C/D R15 M62320 A1
H16 AY237166 A/D R16 U34604 B
H17 AY237167 A/C/D R17 U46016 C
H18 AY255828 C R18 U88824 D
H19 AY531116 B R19 X04415 A/D
H20 AY781125 B R20 AF286238 A
H21 AY829213 B
H22 AY358053 CRF01_AE
H23 AY358054 CRF01_AE
H24 AY358055 CRF01_AE
H25 AY358058 CRF01_AE
H26 AY358061 CRF01_AE
H27 AY037279 CRF12_BF
H28 AY734557 C
H29 AY734561 C
HVau AF407419 O Vau AF407418 O
A simplified designation for each sequence is given along with the accession
number. Although some sequences belonged to ‘pure’ HIV-1 M group clades,
18wererecombinants.Theasteriskservesasa reminderthatHVauandVaudo
not belong to group M, but to the HIV-1 O group.
4678 Nucleic Acids Research, 2006, Vol. 34, No. 17by an unedited sequence. To overcome this, a simple metric
was computed to highlight the effects of editing. The
preferred product of APOBEC3F editing is AA from a GA
substrate, while that for APOBEC3G is AG from a GG
dinucleotide. As both deaminases may be packaged
by a Dvif virion and edit neo-synthesized cDNA, the ratio
(AA + AG)/(GA + GG)—termed PS ratio for ‘product
substrate’—within a sliding window across the sequence
should reveal evidence of APOBEC3 editing. For an ostensi-
bly hypermutated sequence, if editing was infrequent the pro-
ﬁle of PS ratios across the genome should be close to those
for unedited genomes. For a highly edited sequence there
should be considerable deviation from a set of references
sequences. In this latter situation it is possible that AG (CT
on the minus strand) and GA (TC) may be affected. However,
as this would affect both the numerator and denominator, the
impact on the PS ratio may not be too great.
The PS ratio was ﬁrst computed for a series of 20 unedited
HIV-1 M reference sequences (Table 1), as well as the une-
dited HIV-1 group O Vau sequence, to see if there were local
variations across the genome that could hinder interpretation.
As can be seen from Figure 2A for a sliding window of
600 bp the PS ratios varied little through to 5500 with a
local high  5800 bp followed by a decline towards a ratio
close to 1 at  8400 bp. This local peak reﬂects a known ele-
vated A content centered on the ﬁrst hypervariable region of
gp120 and naturally increases the PS ratio. In contrast, the
LTR region is relatively rich in G and so it is not surprising
that the PS ratio is at a minimum from 7500 bp to the end. As
the 20 sequences varied somewhat in length (8751–8864 bp,
D ¼ 1.2%), they were aligned by ClustalW and individual PS
proﬁles recomputed. As this changed little the PS proﬁles
(data not shown), unaligned reference sequences were used
Figure 2. APOBEC3 product/substrate ratio (PS) scans across HIV genomes. (A) PS scans for a collection of 20 unedited HIV-1 M references sequences
(Table 1) starting from the beginning of the Gag orf and running through to the U3 and R regions of the LTR. Hence the numbering system is not that of complete
HIV sequences. The window length was 600 bp displaced at 50 bp intervals. The peak at  5800 corresponds to a known A-rich region centered on the first
hypervariable region in the gp120 coding region. (B) PS scan for HVau along with the mean ± 3 SDs clearly shows that all regions of the HVau genome were
significantly edited by APOBEC3 molecules albeit to different degrees. The positions of the cPPT and 30PPT are indicated.
Figure 1. High-resolution analysis of the hypermutated full-length genome
(HVau) compared to its unedited reference sequence (Vau). To reduce noise
due to small numbers, a 200 bp non-overlapping window was chosen for
analysis. Whether substitutions are normalized to the G (C on the negative
strand) content (black), GG + GA (CC + TC, blue, the preferred context for
APOBEC3 deamination) twin gradients were always observed. No significant
gradient was observed for the GT + GC (AC + GC, red which are avoided by
APOBEC3). The proviral form of the sequence is given along with the cPPT
and 30PPTs.
Nucleic Acids Research, 2006, Vol. 34, No. 17 4679from here on. The PS proﬁle of the group O Vau reference
sequence is indistinguishable from those of HIV-1 group M
sequences (data not shown).
The PS proﬁle for the hypermutated Vau sequence (HVau)
is shown in Figure 2B along with the mean PS ± 3 SDs
computed from the reference sequence set. Throughout, the
PS proﬁle of HVau was signiﬁcantly greater compared to
controls. The proﬁle captures the essential features of the dis-
tribution of edited sites across the genome with twin gradients
50 to the two PPTs (Figure 1).
Wide range in degree of APOBEC3 editing
Given the variable PS ratios across the genome, in the follow-
ing analyses of hypermutated sequences, the mean PS ratio
computed from the 20 HIV-1 M reference sequences was
subtracted. As can be seen the normalized PS ratios, referred
to as PS*, 13 sequences (H2, 3, 5, 7, 11, 13, 14, 17, 19, 22,
26, 27 and 29; Figure 3A) were only slightly edited compared
to controls (PS* < 1) despite the fact that they were anno-
tated as hypermutated. A further 13 sequences (H1, 4, 8, 9,
10, 12, 15, 16, 18, 20, 24, 25 and 28; Figure 3B) were mod-
erately edited with a PS* ratio rarely exceeding 2. In order to
enhance the signal, the PS* values were averaged among the
collection of 13 sequences represented in Figure 3B. As can
be seen twin gradients were apparent (Figure 3C). Only three
sequences (H6, 21 and 23; Figure 3D) exhibited PS* ratios
>2. For this last group, H23 apart (see below), twin gradients
with maxima just 50 to the cPPT and 30PPT were in evidence.
Even for moderately edited sequences gradients were evident
particularly in the ﬁrst half of the sequence (Figure 3B–D,
1–3500 bp). In short, extensively APOBEC3 edited genomes
such as H6, 21, H23 and Vau (4/30 or  13%) are relative
rarities.
To explore further the variable degree of APOBEC3 edit-
ing of these HIV-1 genomes, their overall base composition
was examined (Figure 4). As expected the accumulation of
A is negatively and monotonously correlated to the depletion
of G. Four sequences in particular were particularly lightly
edited, yet appear at the upper end of the distribution for
the reference sequences. Assuming that this small difference
( 0.3%) is due to n APOBEC3 molecules per virion then a
hypermutated genome with an overall A content of  42.2%
would correspond to  19-fold more [(42.2   36.5)/0.3].
Although the minimal value for n ¼ 1, in the close conﬁnes
of a HIV replication complex this translates into a concentra-
tion of the order of 10 mM (27). Hence a 19-fold increase is
synonymous with an enzyme concentration of  0.2 mM
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Figure 3. APOBEC3 product/substrate ratio scans for three groups of hypermutated genomes. Given the somewhat irregular PS ratio across the HIV genome
(Figure 2A) the mean PS ratios for the reference sequences were subtracted from those of the individual hypermutated sequences, yielding the PS* ratio.
(A) A collection of 13 sequences where PS*max <1. The profiles in bold for all four graphs represents the mean + 3 SD derived from the reference sequences.
(B) A collection of 13 sequences where 1<PS*max<2. (C) In order to enhance the signal the PS* values of the 13 sequences represented in B) were averaged.
(D) A collection of 3 sequences where PS*max>2. Note that the ordinate scale varies for all three graphs. The positions of the cPPT and 30PPT are given. As the
PS* ratio for the interval x!x + 600 bp is reported at position x, the PS* ratio starts to decay at cPPT-600 and 30PPT-600. Hence the twin gradients do indeed
reach maxima just 50 to the two PPTs. The sharp break in the PS* ratio for six sequences  7800 results from their being slightly shorter than the reference
sequence set (Figure 5C).
4680 Nucleic Acids Research, 2006, Vol. 34, No. 17which is considerable. Hence it seems plausible, but by no
means proven, that the most lightly edited sequences reﬂect
editing by a single APOBEC3 enzyme.
No PPT orienting of APOBEC3
Given the asymmetry of editing around the two PPT motifs, it
might be posited that the RNA:DNA PPT heteroduplex
remaining following reverse transcription had some orienta-
tion effect on APOBEC3G editing. To explore this we per-
formed an in vitro deamination assay on two loci spanning
the two PPTs in a manner comparable to a previous study
(8). RNA corresponding to 300–400 bp segments spanning
the central and 30PPTs was made in vitro and cDNA was
made using HIV-1 RT which would leave PPT RNA
hybridized to the cDNA. Baculovirus APOBEC3G was pre-
sent from the outset to mimic the events occurring within
the HIV replication complex of a Dvif genome derived
from a non-permissive cell. As can be seen from Figure 5A
and B, editing occurred on either side of both PPTs at similar
frequencies. These observations show that the RNA:DNA
heteroduplex had no orienting effect on APOBEC3G editing.
As can be seen in Figure 5C, 5/18 and 1/20 cDNAs derived
from the in vitro reactions had edited cPPT and 30PPT tracts,
respectively, meaning that either there is a little breathing of
the RNA:DNA heteroduplex or displacement of the RNA
Figure 5. In vitro APOBEC3G editing of nascent HIV PPT cDNA. (A) Cytidine specific deamination frequencies within 338 bp fragment spanning the cPPT.
It encodes 83 G(C) residues and is shown with respect to the reference plus strand. The ordinate gives the frequency of editing for every C residue among
a collection of 20 clones. The box denotes the PPT sequence while the horizontal bars denote the mean cytidine editing frequency on either side of the PPT.
(B) Cytidine specific deamination frequencies within 461 bp fragment spanning the 30PPT, and comprises a total of 143 G(C) residues. (C) Edited PPT sequences
from the two loci shown with respect to the reference sequence. (D) Graphic representation of % site-specific deamination frequencies across the template for
3 and 26 h reactions are plotted on the x and y axes, respectively. The mean site-specific editing frequencies over all sites were 21.9% at 3 h and 53.0% at 26 h.
Hence editing was 2.4-fold more extensive after 26 h incubation. As most of the preferred CC and TC targets are >90%, the 26 h reaction showed signs of
saturation.
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Figure 4. Smooth distribution in the A and G content of HIV-1 M group
hypermutated genomes. The increase in A content is strictly related to the
depletion of G. The large cross represents the mean (35.6%) for the 20
reference sequences. The two data points for the Vau sequences (HIV-1 O)
are displaced towards a lower G content. However, as the gradient is parallel
to that for HIV-1 M group sequences, it may be presumed that there is no
qualitative difference in the way the hypermutated Vau sequences was edited.
Nucleic Acids Research, 2006, Vol. 34, No. 17 4681strand by APOBEC3G. To explore the temporal component
to APOBEC3G editing, a second cPPT cDNA reaction was
incubated with APOBEC3G for 26 h as opposed to 3 h.
Material was recovered by ampliﬁcation and individual
clones were sequenced. As shown in Figure 5D the degree
of editing was increased  2.4-fold compared to the 3 h reac-
tion. Most GG and GA targets were >75% substituted at 26 h.
As would be expected for a simple reaction without product
inhibition, the longer the incubation time, the greater the
degree of editing.
Editing gradients are compatible with HIV
replication dynamics
As there was no orientation effect of the PPT RNA:DNA
heteroduplex on APOBEC3G editing, how might the twin
gradients of APOBEC3 editing be understood? That the
deamination frequency was related to the reaction time
(Figure 5D) suggests a solution related to the mechanics of
HIV replication. HIV-1 DNA synthesis starts with the single-
stranded minus strand primed by tRNAlys3. As soon as the
short PPT RNA primers are generated by the RNaseH func-
tion of RT, double-stranded DNA synthesis proceeds. How-
ever, as only single-stranded DNA is a substrate for
APOBEC3 editing, not all regions remain singled stranded
for the same amount of time. For example, a base 30 proximal
(vis-a `-vis the plus strand) to either of the PPTs will
remain single stranded for a very short time compared to
those several kilobases downstream (Figure 6A). Assuming
a constant velocity for the synthesis of minus (VR) and plus
strand DNA (VD), it is simple to show that fc!u ¼ b[APO-
BEC3]tc ¼ b[APOBEC3](d/VR + d/VD), where fc!u is the
fraction of cytidine residues edited within a small interval
at a distance d between the target cytidine and the upstream
PPT, tc is the time a C residue remains single stranded and
b is a constant. As VR and VD are constants, as is the con-
centration of APOBEC3 for a given virion, this reduces to
fc!u ¼ b0d, where b0 is a constant. In short, the amplitude
of editing is proportional to the distance from the PPT assum-
ing a relatively smooth distribution of dinucleotide targets
across the genome (Figure 6B).
The PS* proﬁle of sequence H23 (28) does not ﬁt the
schema. As shown in Figure 3 the PS* ratios between 2200
and 3500 indicate extensive deamination. By contrast the
surrounding PS* ratios are indistinguishable from those of
the reference sequence set. It is as though H23 represented
a recombinant between two genomes one edited, the other
not. Retroviral recombination presupposes that a hyper-
mutated provirus may be transcribed and its genomic RNA
packaged. Although this is a fascinating question, a posteriori
analysis cannot distinguish it from the result of PCR recomb-
ination (29). Yu et al. (10) noted a gradient in editing across
the HIV genome and sparsely edited LTR sequences immedi-
ately downstream of 30PPT. However, they studied small
PCR fragments across the genome and not near full-length
genomes. As they did not analyze a segment encompassing
the cPPT they concluded that there was a gradient across
the entire genome when in fact there are two gradients in
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Figure 6. Kinetic model of APOBEC3 editing of nascent HIV-1 DNA. (A) Schematic representation of HIV proviral transcription and the first steps of reverse
transcription drawn to scale. PBS, primer binding site; cPPT and 30PPT, central and 30 polypurine tracts. (B) The amplitude of cytidine deamination fc!u is
proportional to the time (t) a base remains single stranded. Assuming that the velocities of RNA- and DNA-dependent reverse transcription (VR and VD) are
constant across the genome, equal access to all sites and a smooth distribution of targets across the sequence, then fc!u ¼ b[APOBEC3]t ¼ bd(1/VR + 1/VD)
where d is the distance of any cytidine residue to the downstream PPT, [APOBEC3] is the concentration of APOBEC3 molecules for a single virion, and b is a
constant. This reduces to fc!u ¼ b0d, where b0 is a constant. Given that the maximum values of d are essentially the same, 4.2 and 4.4 kb for the two regions
primed by synthesis from the 30PPT-PBS and cPPT, this results in twin gradients of similar amplitude. The model predicts that the LTR minus strand is lightly
edited compared to other parts of the genome. Although very few complete hypermutated LTR sequences exist, two papers reported infrequent editing just 30 of
the 30PPT (10,30). (C) Linear schematic indicating the lengths and numbers of sequences used in this study.
4682 Nucleic Acids Research, 2006, Vol. 34, No. 17the same orientation reﬂecting the mechanics of HIV DNA
synthesis. The observation that the LTR is lightly edited
was recently conﬁrmed by Wurtzer et al. (30).
A rather elegant in vitro study of APOBEC3G editing of
DNA showed that for an editing hotspot, the deaminase was
able to jump from 30 to 50 over  100 bp (31). This would
serve to amplify the positional bias in substrate editing across
the genome but could not generate the double gradients with
minima just downstream of the two PPTs. Given that the
study concerned editing hotspots, the phenomenon may intro-
duce local regions of intense editing so explaining additional
peaks in the PS proﬁle, e.g. those  1600–2000 bp for H21,
H23 and Vau (Figure 3). In contrast the in vitro ﬁndings of
aberrant DNA priming on a minus strand DNA template
resulting from total substitution of TTP by dUTP (32) are
not comforted by the present ﬁndings in vivo. Were this to
be the case twin gradients would not be anticipated. This
may be due to the fact that PPT DNA is relatively well
protected from deamination (Figure 5A and B).
Thevariationinthedegreeofeditingofnearfull-lengthgen-
omes indicates a wide range in the number of APOBEC3F/G
molecules packaged per virion (Figures 3 and 4). For a Dvif
virus this could reﬂect differences in the concentration of
APOBEC3 molecules in the donor cell and/or the vagaries
of APOBEC3 packaging. An additional hypothesis may be
that some wild-type genomes encode functional, yet sub-
optimal vif alleles allowing packaging of small numbers
of APOBEC3 molecules. As considerable variation in Vif
function has been shown among alleles derived from clinical
isolates this may be a plausible hypothesis (33). At a practical
level, choosing a locus mapping just 50 to either of the PPTs
would provide a more sensitive readout of function in any
analysis of G!A hypermutation, e.g. analysis of the impact
of a mutation in the APOBEC3G gene.
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